Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Nano Dimension Ltd - ADR (NNDM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Nano Dimension Ltd - ADR — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.71B), while Nano Dimension Ltd - ADR trades at $1.56 (market cap $326.41M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 14.4× Nano Dimension Ltd - ADR's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Nano Dimension Ltd - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Nano Dimension Ltd - ADR for 43 Days on average.
| DFTX | NNDM | |
|---|---|---|
Market Cap | $4.71B | $326.41M |
Volume | 1,966,636 | 774,004 |
Sector | Health | Technology |
52-Week High | $48.45 | $2.14 |
52-Week Low | $10.68 | $1.21 |
Typical Hold Time | 0 Days | 43 Days |
Enterprise Value | $3.67B | -$78.43M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Nano Dimension (NNDM) trades at $1.55, down 1.27% with a bearish technical signal. The company shows concerning fundamentals with a net income margin of -135.18% and negative cash flow from operations of -$101.28M in 2025. Recent strategic actions include cost-saving initiatives and board restructuring, while technical indicators show mixed signals with neutral oscillators but bearish moving averages.
The outlook remains challenging with persistent losses and cash burn despite revenue growth. Investment opportunity exists in the company's strategic repositioning and cash preservation efforts, but risks include continued operational losses, competitive pressures, and execution uncertainty in the additive manufacturing sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →
